A Multiple Dose Study of the Safety and Pharmacology of LY2165766

A Multiple Dose Study of the Safety and Pharmacology of LY2165766 - LY2165766 MAD study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33078

Enrollment

Registered

2009-03-18

Start date

2009-04-20

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

NVT

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy male 18 - 65 Healthy female 45 - 65 postmenopausal/sterilised BMI 18.5 - 32

Exclusion criteria

Exclusion criteria: Relevant medical history

Design outcomes

Primary

Measure	Time frame
NVT	—

Secondary

Measure	Time frame
NVT	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)